US5588962A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug treatment of diseased sites deep within the body
Assignee: Boston Scientific Scimed Inc
•
Filing: 1994-03-29
•
Granted: 1996-12-31
•
Expires: 2014-03-29
Abstract
Abstract A diseased site, such as vascular dilatation site, is treated by first locally delivering to the site an agent that is effective to localize a desired drug and then systematically administering the drug.
Inventors
- 👤 Peter M. Nicholas
- 👤 Ronald A. Sahatjian
- 👤 James J. Barry
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 23:19
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/10; A61M25/104; A61M37/00; A61M2025/1043; A61M2025/105; A61M2025/109
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
163 words
A method for treating a diseased site in a vascular lumen deep within the body of a patient, comprising: (a) providing a drug-localizing agent for a drug that is effective to treat said diseased site, (b) providing a medical device capable of being placed into said vascular lumen at said diseased site and capable of delivering said localizing agent locally at said site, (c) preparing said medical device for delivering said agent at said site, (d) placing said medical device at said site, (e) locally delivering said agent to said site in a manner that said agent is retained at said site, (f) removing said medical device from said vascular lumen, (g) providing said drug effective to treat said diseased site in a form suitable for systemic administration, and (h) systematically administering said drug so that said drug is transported through the body of said patient and localized at said diseased site by the presence of said drug-localizing agent retained at said site.
Claim 2
Independent Claim
163 words
A method for treating a diseased site in a vascular lumen deep within the body of a patient, comprising: (a) providing a drug-localizing agent for a drug that is effective to treat said diseased site, (b) providing a medical device capable of being placed into said vascular lumen at said diseased site and capable of delivering said localizing agent locally at said site, (c) preparing said medical device for delivering said agent at said site, (d) placing said medical device at said site, (e) locally delivering said agent to said site in a manner that said agent is retained at said site, (f) removing said medical device from said vascular lumen, (g) providing said drug effective to treat said diseased site in a form suitable for systemic administration, and (h) systematically administering said drug so that said drug is transported through the body of said patient and localized at said diseased site by the presence of said drug-localizing agent retained at said site.
Claim 3
Dependent Claim
29 words
The method of claim 1 wherein said agent includes an adhesive polymer that adheres to said site, said polymer incorporating a specie that forms a complex with said drug.
Claim 4
Dependent Claim
14 words
The method of claim 1 comprising: delivering said agent to said site under pressure.
Claim 5
Dependent Claim
17 words
The method of claim 1 comprising: delivering said agent to said site with the aid of heat.
Claim 6
Dependent Claim
33 words
The method of claim 1, comprising: monitoring said patient for symptoms of restenosis after removing the medical device from the vascular lumen, and providing and administering said drug after observation of said symptoms.
Claim 7
Dependent Claim
47 words
The method of claim 1 comprising: locally delivering a sufficient amount of said agent to localize an effective amount of said drug from multiple sequential systemic administrations, and systematically administering a sufficient quantity of said drug to effectively treat said site in a sequential fashion as needed.
Claim 8
Dependent Claim
28 words
The method of claim 1 comprising: after systemically delivering a desired drug, delivering additional drug-localizing agent locally to said diseased site and, thereafter systemically delivering additional desired drug.
Claim 9
Dependent Claim
24 words
The method of claim 1 comprising: delivering a mixture of drug-localizing agents effective to concentrate different drugs and systemically administering said drugs as desired.
Claim 10
Dependent Claim
17 words
The method of claim 1 wherein said medical device is a dilatation catheter having an expandable portion.
Claim 11
Dependent Claim
42 words
The method of claim 1 comprising: providing a medical device in the form of a dilation catheter having an expandable portion, expanding said expandable portion to dilate said diseased site, and delivering said agent simultaneously with the dilation of said diseased site.
Claim 12
Dependent Claim
17 words
The method of claim 10 comprising: locally administering the same drug that is to be administered systemically.
Claim 13
Independent Claim
23 words
The method of any one of claims 1, 10, or 11 wherein said expandable portion includes a polymer capable of releasing said agent.
Claim 14
Dependent Claim
19 words
The method of claim 12 when said polymer is a compressible hydrogel capable of releasing said agent when compressed.
Claim 15
Dependent Claim
28 words
The method of claim 12 wherein said expandable portion includes openings or pores or channels through which said agent may pass to deliver said agent to said site.
Claim 16
Dependent Claim
15 words
The method of claim 1 said drug forms a chemical complex with said drug-localizing agent.
Claim 17
Dependent Claim
27 words
The method of claim 15 wherein said drug is an anionic species and said agent is a cationic species in the body lumen environment of said site.
Claim 18
Dependent Claim
15 words
The method of claim 15 wherein said agent is cimetidine and said drug is lidocaine.
Claim 19
Dependent Claim
10 words
The method of claim 15 wherein said drug is heparin.
Claim 20
Dependent Claim
12 words
The method of claim 18 wherein said agent is an ammonium cation.
Claim 21
Dependent Claim
11 words
The method of claim 19 wherein said agent is benzalkonium cation.
Claim 22
Independent Claim
141 words
A method for treating a diseased site in a vascular lumen deep within the body of a patient, comprising: (a) providing a drug-localizing agent for a drug that is effective to treat said diseased site, (b) providing a medical device capable of being placed into said vascular lumen at said diseased site and capable of delivering said localizing agent locally at said site, (c) preparing said medical device for delivering said agent at said site, (d) placing said medical device at said site, (e) locally delivering said agent to said site in a manner that said agent is retained at said site, (f) removing said medical device from said vascular lumen, (g) monitoring said patient for symptoms of restenosis after removing the medical device from the vascular lumen, and (h) systemically administering said drug to said patient having symptoms of restenosis.
Claim 23
Independent Claim
141 words
A method for treating a diseased site in a vascular lumen deep within the body of a patient, comprising: (a) providing a drug-localizing agent for a drug that is effective to treat said diseased site, (b) providing a medical device capable of being placed into said vascular lumen at said diseased site and capable of delivering said localizing agent locally at said site, (c) preparing said medical device for delivering said agent at said site, (d) placing said medical device at said site, (e) locally delivering said agent to said site in a manner that said agent is retained at said site, (f) removing said medical device from said vascular lumen, (g) monitoring said patient for symptoms of restenosis after removing the medical device from the vascular lumen, and (h) systemically administering said drug to said patient having symptoms of restenosis.
Claim 24
Independent Claim
74 words
A method for treating a diseased site deep within the body, comprising: locally delivering to said diseased site a drug-localizing agent using a medical device capable of carrying said agent to and releasing said agent at said site in a manner that the agent is retained at the site, removing the medical device from the body, and systemically delivering drug, said drug being localized at said site by the presence of said localizing agent.
Claim 25
Independent Claim
74 words
A method for treating a diseased site deep within the body, comprising: locally delivering to said diseased site a drug-localizing agent using a medical device capable of carrying said agent to and releasing said agent at said site in a manner that the agent is retained at the site, removing the medical device from the body, and systemically delivering drug, said drug being localized at said site by the presence of said localizing agent.
Claim 26
Dependent Claim
101 words
A kit for delivering a drug-localizing agent to a diseased site in a vascular lumen deep within the body of a patient, comprising: a drug-localizing agent, in a form suitable for local administration that is retained at said site and is effective for localizing a systemically-administered drug to said site, said agent lacking said drug in a form suitable for local administration, and a medical catheter device sized and constructed for placement into said vascular lumen at said diseased site and for delivering said localizing agent locally at said site in a manner that said agent is retained at said site.
Claim 27
Dependent Claim
101 words
A kit for delivering a drug-localizing agent to a diseased site in a vascular lumen deep within the body of a patient, comprising: a drug-localizing agent, in a form suitable for local administration that is retained at said site and is effective for localizing a systemically-administered drug to said site, said agent lacking said drug in a form suitable for local administration, and a medical catheter device sized and constructed for placement into said vascular lumen at said diseased site and for delivering said localizing agent locally at said site in a manner that said agent is retained at said site.
Claim 28
Dependent Claim
124 words
A kit for treating a diseased site in a vascular lumen deep within the body of a patient, comprising: a drug-localizing agent in a form suitable for local administration that is retained at said site and is effective for localizing a systemically-administered drug, said agent lacking said drug in a form suitable for local administration, a drug, in a form suitable for systemic administration, that is effective to treat said diseased site and is localized at said site by prior administration of said localizing agent, and a medical catheter device sized and constructed for placement into said vascular lumen at said diseased site and for delivering said localizing agent locally at said site in a manner that said agent is retained at said site.
Claim 29
Dependent Claim
124 words
A kit for treating a diseased site in a vascular lumen deep within the body of a patient, comprising: a drug-localizing agent in a form suitable for local administration that is retained at said site and is effective for localizing a systemically-administered drug, said agent lacking said drug in a form suitable for local administration, a drug, in a form suitable for systemic administration, that is effective to treat said diseased site and is localized at said site by prior administration of said localizing agent, and a medical catheter device sized and constructed for placement into said vascular lumen at said diseased site and for delivering said localizing agent locally at said site in a manner that said agent is retained at said site.
Claim 30
Dependent Claim
19 words
The method of claim 23 or 24 wherein said medical device is a dilation catheter having an expandable portion.
Claim 31
Dependent Claim
18 words
The method of claim 25 wherein said expandable portion includes a polymer membrane capable of releasing said agent.
Claim 32
Dependent Claim
19 words
The method of claim 26 when said polymer is a compressible hydrogel capable of releasing said agent when compressed.
References Cited (Backward Citations)
DE380205C
Cited
DE1196327B
Cited
US3699956A
Cited
US4026296A
Cited
JPS536430A
Cited
JPS5435036A
Cited
US4299226A
Cited
US4481323A
Cited
US4364392A
Cited
US4330497A
Cited
US4448195A
Cited
GB2112646A
Cited
US4515593A
Cited
US4417576A
Cited
US4423725A
Cited
US4769013A
Cited
SU1069826A1
Cited
US4932934A
Cited
US4820270A
Cited
US4603152A
Cited
US4693243A
Cited
US4714460A
Cited
US4592340A
Cited
US4589873A
Cited
US4876126A
Cited
EP0166998B1
Cited
US5226430A
Cited
US4832688A
Cited
US4784647A
Cited
US4923450A
Cited
US4983166A
Cited
US4950256A
Cited
EP0372088A1
Cited
WO1989012478A1
Cited
US5232444A
Cited
US5252557A
Cited
US5167960A
Cited
US4909258A
Cited
US5213580A
Cited
US5163906A
Cited
US4955377A
Cited
EP0379156A2
Cited
US5091205A
Cited
US5021044A
Cited
US5047045A
Cited
US5041100A
Cited
US4994033A
Cited
EP0399712A1
Cited
US5026607A
Cited
US4993412A
Cited
US5135516A
Cited
WO1991008790A1
Cited
US5209720A
Cited
US5049132A
Cited
US5328471A
Cited
US5199951A
Cited
US5120322A
Cited
US5286254A
Cited
US5180366A
Cited
US5304121A
Cited
WO1992011896A1
Cited
WO1992011895A1
Cited
US5102402A
Cited
US5171217A
Cited
US5295944A
Cited
US5213576A
Cited
EP0526102A1
Cited
US5356433A
Cited
WO1993006792A1
Cited
WO1993011751A1
Cited
US5376376A
Cited
US5301688A
Cited
US5298018A
Cited
US5409012A
Cited
US5470307A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-12-31 | 2000-07-01 | 2000-12-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-12-31 | 2004-07-01 | 2004-12-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-12-31 | 2008-07-01 | 2008-12-31 | $7700.00 | Window Closed / Lapsed |